Concepedia

Katrin Volbracht

KV

6

Publications

816

Citations

6

H-Index

2013

Active since

Affiliations

Wellcome/MRC Cambridge Stem Cell Institute(Current)

University of Cambridge

Medical Research Council

Karolinska Institutet

Heinrich Heine University Düsseldorf

Katrin Volbracht is an author at Wellcome/MRC Cambridge Stem Cell Institute specializing in glioma, cell signaling, and signal transduction.

ORCID

Top concepts

Publications per year

2013–2022

6

Publications

6

Neuregulin and BDNF Induce a Switch to NMDA Receptor-Dependent Myelination by Oligodendrocytes

Iben Lundgaard, A. Luzhynskaya, John H. Stockley et al. · PLoS Biology · 2013 · 328 citations · Full text

Neuronal activity regulates remyelination via glutamate signalling to oligodendrocyte progenitors

Hélène Gautier, Kimberley Anne Evans, Katrin Volbracht et al. · Nature Communications · 2015 · 291 citations · Full text

Surpassing light-induced cell damage in vitro with novel cell culture media

John H. Stockley, Kimberley Anne Evans, Moritz Matthey et al. · Scientific Reports · 2017 · 101 citations · Full text

Iron‐sulfur glutaredoxin 2 protects oligodendrocytes against damage induced by nitric oxide release from activated microglia

Klaudia Lepka, Katrin Volbracht, Eckhard Bill et al. · Glia · 2017 · 46 citations

SHANK3 deficiency leads to myelin defects in the central and peripheral nervous system

Mariagiovanna Malara, Anne-Kathrin Lutz, Berra Incearap et al. · Cellular and Molecular Life Sciences · 2022 · 38 citations · Full text

Rows per page

1–5 of 6